Thomas J. Montine

Thomas J. Montine

Auto-generated profile, based on publicly available information

Thomas J. Montine

Stanford University, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ZHZhi Huang
Zhi Huang
FBFederico Bianchi
Federico Bianchi
MYMert Yuksekgonul
Mert Yuksekgonul
TMThomas J. Montine
Thomas J. Montine
JZJames Y Zou
James Y Zou

11 October 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
LKLeeat Keren
Leeat Keren
MBMarc Bosse
Marc Bosse
STSteve Thompson
Steve Thompson
TRTyler Risom
Tyler Risom
KVKausalia Vijayaragavan
Kausalia Vijayaragavan
MAMichael Angelo
Michael Angelo
Multiplexed, high resolution analysis with MIBI-TOF reveals surprising features of the immune environment across tumor regions.

26 October 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MCM. Ryan Corces
M. Ryan Corces
ASAnna Shcherbina
Anna Shcherbina
SKSoumya Kundu
Soumya Kundu
MGMichael J. Gloudemans
Michael J. Gloudemans
LFLaure Frésard
Laure Frésard
TMThomas J. Montine
Thomas J. Montine

15 June 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
HBHind Bouzid
Hind Bouzid
JBJulia A. Belk
Julia A. Belk
MJMax Jan
Max Jan
YQYanyan Qi
Yanyan Qi
CSChloé Sarnowski
Chloé Sarnowski
SJSiddhartha Jaiswal
Siddhartha Jaiswal
Clonal hematopoiesis of indeterminate potential (CHIP) is a premalignant expansion of mutated hematopoietic stem cells. As CHIP-associated mutations are known to alter the development and function of myeloid cells, we hypothesized that CHIP may also be associated with the risk of Alzheimer’s disease (AD), a disease in which brain-resident myeloid cells are thought to have a major role. To perform association tests between CHIP and AD dementia, we analyzed blood DNA sequencing data from 1,362 individuals with AD and 4,368 individuals without AD. Individuals with CHIP had a lower risk of AD dementia (meta-analysis odds ratio (OR) = 0.64, P = 3.8 × 10−5), and Mendelian randomization analyses supported a potential causal association. We observed that the same mutations found in blood were also detected in microglia-enriched fraction of the brain in seven of eight CHIP carriers. Single-nucleus chromatin accessibility profiling of brain-derived nuclei in six CHIP carriers revealed that the mutated cells comprised a large proportion of the microglial pool in the samples examined. While additional studies are required to validate the mechanistic findings, these results suggest that CHIP may have a role in attenuating the risk of AD.

11 March 2019 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
TMThomas J. Montine
Thomas J. Montine
BCBrenna A. Cholerton
Brenna A. Cholerton
MCMaria Corrada-Bravo
Maria Corrada-Bravo
SESteven D. Edland
Steven D. Edland
MFMargaret E. Flanagan
Margaret E. Flanagan
LWLon R. White
Lon R. White
A primary goal of research in cognitive impairment and dementia is to understand how some individuals retain sufficient cognitive function for a fulfilling life while many others are robbed of their independence, sometimes their essence, in the last years and decades of life. In this commentary, we propose operational definitions of the types of factors that may help individuals retain cognitive function with aging. We propose operational definitions of resistance, resilience, reserve, with an eye toward how these may be measured and interpreted, and how they may enable research aimed at prevention. With operational definitions and quantification of resistance, resilience, and reserve, a focused analytic search for their determinants and correlates can be undertaken. This approach, essentially a search to identify protective risk factors and their mechanisms, represents a relatively unexplored pathway toward the identification of candidate preventive interventions.

7 August 2019 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
DMDunja Mrdjen
Dunja Mrdjen
EFEdward J. Fox
Edward J. Fox
SBSyed A. Bukhari
Syed A. Bukhari
KMKathleen S. Montine
Kathleen S. Montine
SBSean C. Bendall
Sean C. Bendall
TMThomas J. Montine
Thomas J. Montine